Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Fourth-Generation CAR-T in the Treatment of Hematologic Malignancies

NCT06758713 is registered in ClinicalTrials.gov with The Third Affiliated Hospital of Southern Medical University as lead sponsor.

NCT NCT06758713
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06758713 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Fourth-Generation CAR-T in the Treatment of Hematologic Malignancies
Lead sponsor
The Third Affiliated Hospital of Southern Medical University
Phase
Phase 1
Overall status
Recruiting
Start date
January 15, 2025
Completion date
December 31, 2028
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

b-cell lymphoma, hematological malignancy, multiple myeloma